Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month resultsRobert E. Coleman, Nigel Bundred, Antonio Llombart‐Cussac et al.|Annals of Oncology|2012Cited by 337